PLCG2 and Alzheimer disease: Furthermore, it was recently discovered that rare loss-of-function variants in PLCG2 increase AD risk via nonsense-mediated mRNA decay [15], suggesting that the degree of enzymatic activity of PLCγ2 is the key determinant of whether PLCG2 variants mediate risk-increasing or protective effects on AD or other diseases.